Bridgewater Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bridgewater Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$583K	Hold	3,958	–	–	0.03%	241
2026 Q1	$538K	Hold	3,958	–	–	0.03%	234
2025 Q4	$507K	Hold	3,958	–	–	0.03%	254
2025 Q3	$433K	Sell	3,958 -278	-7%	-$25K	0.03%	277
2025 Q2	$364K	Sell	4,236 -697	-14%	-$55.6K	0.03%	309
2025 Q1	$404K	Buy	+4,933	New	+$441K	0.04%	268
2022 Q3	–	Sell	-8,937	Closed	-$664K	–	229
2022 Q2	$664K	Hold	8,937	–	–	0.14%	117
2022 Q1	$803K	Hold	8,937	–	–	0.2%	101
2021 Q4	$1M	Hold	8,937	–	–	0.22%	97
2021 Q3	$1.12M	Sell	8,937 -350	-4%	-$45.1K	0.31%	76
2021 Q2	$1.26M	Buy	9,287 +899	+11%	+$118K	0.4%	68
2021 Q1	$1.04M	Buy	+8,388	New	+$1.26M	0.53%	54
2014 Q2	$1.79M	Buy	+34,932	New	+$1.57M	1.5%	23

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Bridgewater Advisors's XBI Position: Q2 2026 in Review

Bridgewater Advisors held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 3,958 shares worth $583K. The position accounts for 0.03% of the portfolio, ranked #241.

Bridgewater Advisors first reported a position in XBI in Q2 2014 and has held it in 13 quarters since. The position peaked at $1.79M in Q2 2014. 936 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Bridgewater Advisors held 3,958 shares of State Street SPDR S&P Biotech ETF worth $583K as of Q2 2026.
Bridgewater Advisors left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.03% of Bridgewater Advisors's portfolio in Q2 2026, its #241 holding.
Bridgewater Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2014 and has held it in 13 quarters since.
Bridgewater Advisors's State Street SPDR S&P Biotech ETF position peaked at $1.79M in Q2 2014.
936 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Bridgewater Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.